Latest news articles

Added 7 hours ago Drug news

SUSTAIN 8 and 10 Phase III trials of Ozempic show Ozempic superior in type 2 diabetes.- Novo Nordisk

Novo Nordisk announced the results from two Ozempic (once-weekly semaglutide 1.0 mg) head-to-head Phase III clinical trials, SUSTAIN 8 and...

Added 2 days ago Drug news

Sanofi and Abbott partner to integrate glucose sensing and insulin delivery technologies to help change the way diabetes is managed

Sanofi and Abbott are partnering to integrate glucose sensing and insulin delivery technologies that would help to further simplify how...

Added 2 days ago Drug news

Lexicon Pharmaceuticals announced the termination of its alliance with Sanofi for the development and commercialization of Zynquista in both type 1 and type 2 diabetes

Lexicon Pharmaceuticals, Inc. announced the termination of its alliance with Sanofi for the development and commercialization of Zynquista (sotagliflozin) and...

Search all news articles for Diabetes mellitus without complication
 

 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Cushing's Syndrome

Cushing's Syndrome

Cushing’s syndrome shares symptoms such as hypertension, glucose intolerance and obesity with other common conditions – how can you confidently diagnose this rare disorder?

+ 2 more

Cardiovascular Metabolism Knowledge Centre

Cardiovascular Metabolism Knowledge Centre

The Cardiovascular Metabolism Knowledge Centre is an information hub providing expert insight into the management of hypertension and type 2 diabetes. This Knowledge Centre contains a wealth of scientific video content offering insights and opinion from some of the leading experts in the field.

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more

Load more

 

Guidelines

Long-acting reversible contraception

This guideline covers long-acting reversible contraception. It aims to increase the use of long-action reversible contraception by improving the information given to women about their contraceptive choices.

Added 13 years ago

Hyperparathyroidism (primary): diagnosis, assessment and initial management

This guideline covers diagnosing, assessing and managing primary hyperparathyroidism. It aims to improve recognition and treatment of this condition, reducing long‑term complications and improving quality of life.

Added 1 month ago

UrgoStart for treating diabetic foot ulcers and leg ulcers

UrgoStart is a type of interactive wound dressing. Clinical trial evidence shows that using UrgoStart to treat diabetic foot ulcers increases wound healing compared with non-interactive dressings.

Added 2 months ago

Search all guidelines for Endocrinology
 

Journal articles

Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives.

Sotagliflozin is a dual sodium–glucose co-transporter-2 and 1 (SGLT2/1) inhibitor for the treatment of both type 1 (T1D) and type 2 diabetes (T2D). Sotagliflozin inhibits renal sodium–glucose co-transporter 2...

Added 8 days ago

Sotagliflozin: First Global Approval.

Sotagliflozin (Zynquista™) is a dual inhibitor of sodium-glucose co-transporters (SGLT) 1 and 2 being developed by Lexicon Pharmaceuticals and Sanofi as a treatment for type 1 (T1DM) and type 2 diabetes mellitus (T2DM).

Added 8 days ago

Channelopathies.

Channelopathies are a heterogeneous group of disorders resulting from the dysfunction of ion channels located in the membranes of all cells and many cellular organelles. These include diseases of the nervous system (e.g., generalized epilepsy...

Added 1 month ago

Search all journal articles for Endocrinology
 

Clinical trials

A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 Diabetes (PIONEER 12)

This study compares 2 medicines for type 2 diabetes: oral semaglutide (a new medicine) and sitagliptin (a medicine doctors can already prescribe). Participants will either get oral semaglutide or sitagliptin - which treatment is decided by chance.

Added 2 months ago

A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes (SURPASS-2)

The reason for this study is to compare the effect of the study drug tirzepatide to semaglutide on blood sugar levels in participants with type 2 diabetes. The study will last approximately 47 weeks and may include about 12 visits.

Added 2 months ago

Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea (AMPLITUDE-S)

To demonstrate the superiority of once weekly injection of efpeglenatide in comparison to placebo in glycated hemoglobin (HbA1c) change in participants with type 2 diabetes mellitus (T2DM) inadequately controlled with...

Added 2 months ago

Search all clinical trials for Endocrinology
 

Blog Posts

Adam Jeffery

Transforming Lives Through Technology: Diabetes

Posted 4 months ago

Right now, with a swipe or tap, I can tell you how many calories I’ve consumed, how far I’ve walked and how well I slept last night. However, digital health technology and its analytics have mixed reviews from the general public, some become obsessed wanting to know every macronutrient that goes into their body and others see it as just another gimmick. But what about those with chronic conditions like diabetes?

Robin Hewings

Diabetes Patients Must Be Better Educated About Their Condition

Posted 3 years ago

Not everyone is convinced that education courses help people look after their diabetes. And the GP I was chatting to a couple of months ago was one of them. He wasn’t sure they worked. People didn’t seem that interested and he wasn’t really sure what people would learn anyway.

Hugh Harvey

Metrics Madness

Posted 3 years ago

You shouldn't judge a book by its cover. That much is true, but it's also common sense not to judge a book by measuring the whiteness of its pages, or the amount of hamsters you can place on it. So why do we measure the fabulous NHS with nonsense metrics?

CME

Step by step: how to diagnose and manage type 1 diabetes in adults in primary care

Accrediting body
BMJ Learning - British Medical Learning
Credits available
1
Registration required
1
Subscription fee
90

Clinical pointers: Blood glucose control in type 2 diabetes

Accrediting body
BMJ Learning - British Medical Learning
Credits available
1
Registration required
1
Subscription fee
90

Clinical pointers: recognising and managing acute complications of diabetes in adults

Accrediting body
BMJ Learning - British Medical Learning
Credits available
1
Registration required
1
Subscription fee
90
Search all CME for Endocrinology